持続血糖測定装置市場規模、成長と動向分析レポート 2025-2033年

Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report

Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Standalone, Integrated), By Connectivity, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

商品番号 : SMB-88122

出版社Grand View Research
出版年月2025年8月
ページ数195
価格タイプシングルユーザライセンス
価格USD 5,950
種別英文調査報告書

持続血糖測定装置市場 – 製品(スタンドアロン、統合型)、接続性別、適応症別、流通チャネル別、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2033年

持続血糖測定装置の市場規模は、2024年には136億6,000万米ドルと推定され、2025年から2033年にかけて年平均成長率15.44%で成長し、2033年には498億7,000万米ドルに達すると予測されています。この成長は、臨床ニーズ、技術革新、ケアモデルの変化によるものです。

市場成長のもう一つの主要要因は、世界的な糖尿病罹患率の上昇です。これにより、より効率的でリアルタイムな血糖モニタリングソリューションへの需要が高まっています。従来の血糖値検査は、侵襲性が高く、断続的で、煩わしい場合が多いため、患者と医療従事者の両方が、より良い血糖コントロールと生活の質の向上を目指してCGMシステムの導入を促しています。国際糖尿病連合(IDF)によると、2024年現在、世界中で約5億8,900万人の成人が糖尿病を患っています。

Continuous Glucose Monitoring Devices Market Summary

The continuous glucose monitoring devices market size was estimated at USD 13.66 billion in 2024 and is projected to reach USD 49.87 billion by 2033, growing at a CAGR of 15.44% from 2025 to 2033. This growth is attributed to clinical needs, technological innovation, and shifting care models.

持続血糖測定装置市場規模、成長と動向分析レポート 2025-2033年
Continuous Glucose Monitoring Devices Market

Another primary factor for market growth is the rising global prevalence of diabetes, which has intensified the demand for more efficient and real-time glucose monitoring solutions. Traditional blood glucose testing is often invasive, intermittent, and inconvenient, prompting both patients and providers to adopt CGM systems for better glycemic control and improved quality of life. According to the International Diabetes Federation (IDF), as of 2024, there are approximately 589 million adults living with diabetes worldwide.

Continuous Glucose Monitoring (CGM) Devices Market Report Scope

Report AttributeDetails
Market size value in 2025USD 15.81 billion
Revenue forecast in 2033USD 49.87 billion
Growth rateCAGR of 15.44% from 2025 to 2033
Base year for estimation2024
Historical data2021 – 2023
Forecast period2025 – 2033
Quantitative unitsRevenue in USD million/billion and CAGR from 2025 to 2033
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredProduct, connectivity, indication, distribution channel, region
Regional scopeNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scopeU.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.
Key companies profiledDexCom, Inc.; Abbott Laboratories; Medtronic plc; Senseonics Holdings, Inc.; Insulet Corporation; Tandem Diabetes Care; Ascenia Diabetes Care (subsidiary of PHC Holdings); AgaMatrix, Inc.; GlucoRx Limited; Zhejiang POCTech Co., Ltd.; i-SENS, Inc.; F. Hoffmann-La Roche Ltd.
Customization scopeFree report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Global Continuous Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global continuous glucose monitoring (CGM) devices market report based on the product, connectivity, indication, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 – 2033)
  • Standalone CGM Devices

o Devices

o Consumables

  • Integrated-CGM Insulin Pump Systems
  • Connectivity Outlook (Revenue, USD Million, 2021 – 2033)
  • Bluetooth
  • 4G/Cellular
  • Near Field Communication (NFC)
  • Indication Outlook (Revenue, USD Million, 2021 – 2033)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Distribution Channel Outlook (Revenue, USD Million, 2021 – 2033)
  • Pharmacies
  • E-commerce
  • Other
  • Region Outlook (Revenue, USD Million, 2021 – 2033)
  • North America

o U.S.

o Canada

o Mexico

  • Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

  • Asia Pacific

o Japan

o China

o India

o Australia

o South Korea

o Thailand

  • Latin America

o Brazil

o Argentina

  • Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Segment Definitions

1.2.1. Product

1.2.2. Connectivity

1.2.3. Indication

1.2.4. Distribution Channel

1.2.5. Regional scope

1.2.6. Estimates and forecasts timeline

1.3. Research Methodology

1.4. Information Procurement

1.4.1. Purchased database

1.4.2. GVR’s internal database

1.4.3. Secondary sources

1.4.4. Primary research

1.4.5. Details of primary research

1.5. Information or Data Analysis

1.5.1. Data analysis models

1.6. Market Formulation & Validation

1.7. Model Details

1.7.1. Commodity flow analysis (Model 1)

1.7.2. Approach 1: Commodity flow approach

1.7.3. Volume price analysis (Model 2)

1.7.4. Approach 2: Volume price analysis

1.8. List of Secondary Sources

1.9. List of Primary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Product outlook

2.2.2. Connectivity outlook

2.2.3. Indication outlook

2.2.4. Distribution channel outlook

2.2.5. Regional outlook

2.3. Competitive Insights

Chapter 3. Continuous Glucose Monitoring (CGM) Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Rising number of diabetes cases

3.2.1.2. Shift towards preventive and personalized care

3.2.1.3. Technological advancements and device innovation

3.2.1.4. Expansion of reimbursement and insurance coverage

3.2.2. Market Restraint Analysis

3.2.2.1. High cost of CGM devices

3.2.2.2. Data accuracy and technical limitations

3.3. Continuous Glucose Monitoring (CGM) Devices Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Bargaining power of suppliers

3.3.1.2. Bargaining power of buyers

3.3.1.3. Threat of substitutes

3.3.1.4. Threat of new entrants

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Economic landscape

3.3.2.3. Social landscape

3.3.2.4. Technological landscape

3.3.2.5. Environmental landscape

3.3.2.6. Legal landscape

Chapter 4. Continuous Glucose Monitoring (CGM) Devices Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Continuous Glucose Monitoring (CGM) Devices Market: Product Movement Analysis

4.3. Continuous Glucose Monitoring (CGM) Devices Market by Product Outlook (USD Million)

4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

4.5. Standalone CGM Devices

4.5.1. Standalone CGM Devices Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.5.2. Devices

4.5.2.1. Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.5.3. Consumables

4.5.3.1. Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.6. Integrated-CGM Insulin Pump Systems

4.6.1. Integrated-CGM Insulin Pump Systems Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 5. Continuous Glucose Monitoring (CGM) Devices Market: Connectivity Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Continuous Glucose Monitoring (CGM) Devices Market: Connectivity Movement Analysis

5.3. Continuous Glucose Monitoring (CGM) Devices Market by Connectivity Outlook (USD Million)

5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

5.5. Bluetooth

5.5.1. Bluetooth Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

5.6. 4G/Cellular

5.6.1. 4G/Cellular Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

5.7. Near Field Communication (NFC)

5.7.1. Near Field Communication Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 6. Continuous Glucose Monitoring (CGM) Devices Market: Indication Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. Continuous Glucose Monitoring (CGM) Devices Market: Indication Movement Analysis

6.3. Continuous Glucose Monitoring (CGM) Devices Market by Indication Outlook (USD Million)

6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

6.5. Type 1 Diabetes

6.5.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

6.6. Type 2 Diabetes

6.6.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 7. Continuous Glucose Monitoring (CGM) Devices Market: Distribution Channel Estimates & Trend Analysis

7.1. Segment Dashboard

7.2. Continuous Glucose Monitoring (CGM) Devices Market: Distribution Channel Movement Analysis

7.3. Continuous Glucose Monitoring (CGM) Devices Market by Distribution Channel Outlook (USD Million)

7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

7.5. Pharmacies

7.5.1. Pharmacies Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

7.6. E-commerce

7.6.1. E-commerce Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7. Other

7.7.1. Other Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 8. Continuous Glucose Monitoring (CGM) Devices Market: Regional Estimates & Trend Analysis

8.1. Regional Dashboard

8.2. Regional Continuous Glucose Monitoring (CGM) Devices Market Movement Analysis

8.3. Continuous Glucose Monitoring (CGM) Devices Market: Regional Estimates & Trend Analysis by Product & End-use

8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

8.5. North America

8.5.1. North America Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.2. U.S.

8.5.2.1. Key Country Dynamics

8.5.2.2. Competitive Scenario

8.5.2.3. Regulatory Framework

8.5.2.4. Reimbursement scenario

8.5.2.5. U.S. Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.3. Canada

8.5.3.1. Key Country Dynamics

8.5.3.2. Competitive Scenario

8.5.3.3. Regulatory Framework

8.5.3.4. Reimbursement scenario

8.5.3.5. Canada Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.4. Mexico

8.5.4.1. Key Country Dynamics

8.5.4.2. Competitive Scenario

8.5.4.3. Regulatory Framework

8.5.4.4. Reimbursement scenario

8.5.4.5. Mexico Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.5. Europe

8.5.6. Europe Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.7. UK

8.5.7.1. Key Country Dynamics

8.5.7.2. Competitive Scenario

8.5.7.3. Regulatory Framework

8.5.7.4. Reimbursement scenario

8.5.7.5. UK Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.8. Germany

8.5.8.1. Key Country Dynamics

8.5.8.2. Competitive Scenario

8.5.8.3. Regulatory Framework

8.5.8.4. Reimbursement scenario

8.5.8.5. Germany Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.9. France

8.5.9.1. Key Country Dynamics

8.5.9.2. Competitive Scenario

8.5.9.3. Regulatory Framework

8.5.9.4. Reimbursement scenario

8.5.9.5. France Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.10. Italy

8.5.10.1. Key Country Dynamics

8.5.10.2. Competitive Scenario

8.5.10.3. Regulatory Framework

8.5.10.4. Reimbursement scenario

8.5.10.5. Italy Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.11. Spain

8.5.11.1. Key Country Dynamics

8.5.11.2. Competitive Scenario

8.5.11.3. Regulatory Framework

8.5.11.4. Reimbursement scenario

8.5.11.5. Spain Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.12. Denmark

8.5.12.1. Key Country Dynamics

8.5.12.2. Competitive Scenario

8.5.12.3. Regulatory Framework

8.5.12.4. Reimbursement scenario

8.5.12.5. Denmark Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.13. Sweden

8.5.13.1. Key Country Dynamics

8.5.13.2. Competitive Scenario

8.5.13.3. Regulatory Framework

8.5.13.4. Reimbursement scenario

8.5.13.5. Sweden Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5.14. Norway

8.5.14.1. Key Country Dynamics

8.5.14.2. Competitive Scenario

8.5.14.3. Regulatory Framework

8.5.14.4. Reimbursement scenario

8.5.14.5. Norway Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6. Asia Pacific

8.6.1. Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6.2. Japan

8.6.2.1. Key Country Dynamics

8.6.2.2. Competitive Scenario

8.6.2.3. Regulatory Framework

8.6.2.4. Reimbursement scenario

8.6.2.5. Japan Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6.3. China

8.6.3.1. Key Country Dynamics

8.6.3.2. Competitive Scenario

8.6.3.3. Regulatory Framework

8.6.3.4. Reimbursement scenario

8.6.3.5. China Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6.4. India

8.6.4.1. Key Country Dynamics

8.6.4.2. Competitive Scenario

8.6.4.3. Regulatory Framework

8.6.4.4. Reimbursement scenario

8.6.4.5. India Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6.5. South Korea

8.6.5.1. Key Country Dynamics

8.6.5.2. Competitive Scenario

8.6.5.3. Regulatory Framework

8.6.5.4. Reimbursement scenario

8.6.5.5. South Korea Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6.6. Australia

8.6.6.1. Key Country Dynamics

8.6.6.2. Competitive Scenario

8.6.6.3. Regulatory Framework

8.6.6.4. Reimbursement scenario

8.6.6.5. Australia Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6.7. Thailand

8.6.7.1. Key Country Dynamics

8.6.7.2. Competitive Scenario

8.6.7.3. Regulatory Framework

8.6.7.4. Reimbursement scenario

8.6.7.5. Thailand Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.7. Latin America

8.7.1. Latin America Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.7.2. Brazil

8.7.2.1. Key Country Dynamics

8.7.2.2. Competitive Scenario

8.7.2.3. Regulatory Framework

8.7.2.4. Reimbursement scenario

8.7.2.5. Brazil Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.7.3. Argentina

8.7.3.1. Key Country Dynamics

8.7.3.2. Competitive Scenario

8.7.3.3. Regulatory Framework

8.7.3.4. Reimbursement scenario

8.7.3.5. Argentina Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.8. Middle East & Africa

8.8.1. Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.8.2. South Africa

8.8.2.1. Key Country Dynamics

8.8.2.2. Competitive Scenario

8.8.2.3. Regulatory Framework

8.8.2.4. Reimbursement scenario

8.8.2.5. South Africa Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.8.3. Saudi Arabia

8.8.3.1. Key Country Dynamics

8.8.3.2. Competitive Scenario

8.8.3.3. Regulatory Framework

8.8.3.4. Reimbursement scenario

8.8.3.5. Saudi Arabia Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.8.4. UAE

8.8.4.1. Key Country Dynamics

8.8.4.2. Competitive Scenario

8.8.4.3. Regulatory Framework

8.8.4.4. Reimbursement scenario

8.8.4.5. UAE Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.8.5. Kuwait

8.8.5.1. Key Country Dynamics

8.8.5.2. Competitive Scenario

8.8.5.3. Regulatory Framework

8.8.5.4. Reimbursement scenario

8.8.5.5. Kuwait Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization

9.2. Key Company Profiles

9.2.1. DexCom, Inc.

9.2.1.1. Company overview

9.2.1.2. Financial performance

9.2.1.3. Product benchmarking

9.2.1.4. Strategic initiatives

9.2.2. Abbott Laboratories

9.2.2.1. Company overview

9.2.2.2. Financial performance

9.2.2.3. Product benchmarking

9.2.2.4. Strategic initiatives

9.2.3. Medtronic plc

9.2.3.1. Company overview

9.2.3.2. Financial performance

9.2.3.3. Product benchmarking

9.2.3.4. Strategic initiatives

9.2.4. Sensonics Holdings, Inc.

9.2.4.1. Company overview

9.2.4.2. Financial performance

9.2.4.3. Product benchmarking

9.2.4.4. Strategic initiatives

9.2.5. Insulet Corporation

9.2.5.1. Company overview

9.2.5.2. Financial performance

9.2.5.3. Product benchmarking

9.2.5.4. Strategic initiatives

9.2.6. Tandem Diabetes Care

9.2.6.1. Company overview

9.2.6.2. Financial performance

9.2.6.3. Product benchmarking

9.2.6.4. Strategic initiatives

9.2.7. Ascenia Diabetes Care (subsidiary of PHC Holdings)

9.2.7.1. Company overview

9.2.7.2. Financial performance

9.2.7.3. Product benchmarking

9.2.7.4. Strategic initiatives

9.2.8. AgaMatrix, Inc.

9.2.8.1. Company overview

9.2.8.2. Financial performance

9.2.8.3. Product benchmarking

9.2.8.4. Strategic initiatives

9.2.9. GlucoRx Limited

9.2.9.1. Company overview

9.2.9.2. Financial performance

9.2.9.3. Product benchmarking

9.2.9.4. Strategic initiatives

9.2.10. Zhejiang POCTech., Ltd.

9.2.10.1. Company overview

9.2.10.2. Financial performance

9.2.10.3. Product benchmarking

9.2.10.4. Strategic initiatives

9.2.11. iSENS, Inc.

9.2.11.1. Company overview

9.2.11.2. Financial performance

9.2.11.3. Product benchmarking

9.2.11.4. Strategic initiatives

9.2.12. F. Hoffmann-La Roche Ltd.

9.2.12.1. Company overview

9.2.12.2. Financial performance

9.2.12.3. Product benchmarking

9.2.12.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources

Table 2 List of abbreviations

Table 3 Global Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 4 Global Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 5 Global Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 6 Global Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel (USD Million) 2021 – 2033

Table 7 North America Continuous Glucose Monitoring (CGM) Devices Market, by region, 2021 – 2033 (USD Million)

Table 8 North America Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 9 North America Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021- 2033 (USD Million)

Table 10 North America Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 11 North America Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 12 U.S. Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 13 U.S. Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 14 U.S. Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 15 U.S. Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 16 Canada Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 17 Canada Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 18 Canada Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 19 Canada Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 20 Mexico Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 21 Mexico Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 22 Mexico Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 23 Mexico Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 24 Europe Continuous Glucose Monitoring (CGM) Devices Market, by Country, 2021 – 2033 (USD Million)

Table 25 Europe Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 26 Europe Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 27 Europe Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 28 Europe Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 29 UK Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 30 UK Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 31 UK Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 32 UK Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 33 Germany Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 34 Germany Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 35 Germany Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 36 Germany Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 37 France Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 38 France Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 39 France Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 40 France Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 41 Italy Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 42 Italy Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 43 Italy Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 44 Italy Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 45 Spain Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 46 Spain Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 47 Spain Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 48 Spain Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 49 Norway Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 50 Norway Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 51 Norway Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 52 Norway Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 53 Sweden Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 54 Sweden Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 55 Sweden Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 56 Sweden Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 57 Denmark Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 58 Denmark Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 59 Denmark Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 60 Denmark Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 61 Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market, by Country, 2021 – 2033 (USD Million)

Table 62 Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 63 Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 64 Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 65 Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 66 Japan Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 67 Japan Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 68 Japan Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 69 Japan Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 70 China Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 71 China Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 72 China Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 73 China Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 74 India Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 75 India Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 76 India Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 77 India Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 78 Australia Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 79 Australia Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 80 Australia Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 81 Australia Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 82 South Korea Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 83 South Korea Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 84 South Korea Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 85 South Korea Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 86 Thailand Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 87 Thailand Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 88 Thailand Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 89 Thailand Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 90 Latin America Continuous Glucose Monitoring (CGM) Devices Market, by Country, 2021 – 2033 (USD Million)

Table 91 Latin America Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 92 Latin America Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 93 Latin America Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 94 Latin America Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 95 Brazil Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 96 Brazil Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 97 Brazil Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 98 Argentina Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 99 Argentina Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 100 Argentina Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 101 Argentina Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 102 Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market, by Country, 2021 – 2033 (USD Million)

Table 103 Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 104 Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 105 Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 106 Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 107 South Africa Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 108 South Africa Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 109 South Africa Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 110 South Africa Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 111 Saudi Arabia Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 112 Saudi Arabia Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 113 Saudi Arabia Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 114 Saudi Arabia Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 115 UAE Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 116 UAE Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 117 UAE Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 118 UAE Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

Table 119 Kuwait Continuous Glucose Monitoring (CGM) Devices Market, by Product, 2021 – 2033 (USD Million)

Table 120 Kuwait Continuous Glucose Monitoring (CGM) Devices Market, by Connectivity, 2021 – 2033 (USD Million)

Table 121 Kuwait Continuous Glucose Monitoring (CGM) Devices Market, by Indication, 2021 – 2033 (USD Million)

Table 122 Kuwait Continuous Glucose Monitoring (CGM) Devices Market, by Distribution Channel, 2021 – 2033 (USD Million)

List of Figures

Fig. 1 Information Procurement

Fig. 2 Primary Research Pattern

Fig. 3 Market Research Approaches

Fig. 4 Value Chain-Based Sizing & Forecasting

Fig. 5 Market Formulation & Validation

Fig. 6 Continuous Glucose Monitoring (CGM) Devices Market segmentation

Fig. 7 Market driver analysis (Current & future impact)

Fig. 8 Market restraint analysis (Current & future impact)

Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)

Fig. 10 Porter’s Five Forces Analysis

Fig. 11 Continuous glucose monitoring (CGM) Devices Market, product outlook key takeaways (USD Million)

Fig. 12 Continuous glucose monitoring (CGM) devices market: product movement analysis (USD Million), 2024 & 2033

Fig. 13 Standalone CGM devices market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 14 Devices market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 15 Consumables market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 16 Integrated-CGM insulin pump systems market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 17 Continuous glucose monitoring (CGM) devices market, connectivity outlook key takeaways (USD Million)

Fig. 18 Continuous glucose monitoring (CGM) devices market connectivity movement analysis (USD Million), 2024 & 2033

Fig. 19 Bluetooth market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 20 4G/Cellular market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 21 Near field communication (NFC) market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 22 Continuous glucose monitoring (CGM) devices market, indication outlook key takeaways (USD Million)

Fig. 23 Continuous glucose monitoring (CGM) devices market indication movement analysis (USD Million), 2024 & 2033

Fig. 24 Type 1 diabetes market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 25 Type 2 diabetes market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 26 Continuous glucose monitoring (CGM) devices market, distribution channel outlook key takeaways (USD Million)

Fig. 27 Continuous glucose monitoring (CGM) devices market distribution channel movement analysis (USD Million), 2024 & 2033

Fig. 28 Pharmacies market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 29 E-commerce market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 30 Others market revenue estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 31 Continuous glucose monitoring (CGM) devices market: Regional key takeaways (USD Million)

Fig. 32 Continuous glucose monitoring (CGM) devices market regional outlook, 2024 & 2033, USD Million

Fig. 33 North America continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 34 U.S. continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 35 Canada continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 36 Mexico continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 37 Europe continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 38 UK continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 39 Germany continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 40 France continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 41 Spain continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 42 Italy continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 43 Sweden continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 44 Norway continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 45 Denmark continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 46 Asia Pacific continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 47 China continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 48 Japan continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 49 India continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 50 South Korea continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 51 Australia continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 52 Thailand continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 53 Latin America continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 54 Brazil continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 55 Argentina continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 56 Middle East and Africa continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 57 South Africa continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 58 Saudi Arabia continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 59 UAE continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 60 Kuwait continuous glucose monitoring (CGM) devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 61 List of key emerging company’s/indication disruptors/innovators